Report: White Biotechnology

About the Report:

Japan is among the most developed industrialised nations in terms of science and technology (S&T). As innovation in industrial biotechnology is of long-standing priority in the national S&T policy, Japanese companies, often supported by large international trading houses or by governmental institutions, are continuously on alert for innovations abroad. This constitutes an excellent opportunity for European start-ups and SMEs which develop innovative products or technologies to partner with Japanese stakeholders. However, large distances and different business cultures must be patiently bridged to succeed in business development. Thus, this report titled 'Industrial (“White”) Biotechnology in Japan: Company Activities and Government Programs – and How to Become Involved. A Primer for European SMEs' describes some of the mechanisms by which European SMEs can get involved and how such partnering can be achieved.

About the Expert

Rolf SCHMID, Senior Consultant & CEO, Bio4Business - SCHMID Rolf

The recording of the past webinar covering this topic is available for online viewers here. (Once you are logged in, look for the link below the "After event information") 

Picture: Forest - National Museum of Nature and Science, Tokyo
Copyright: Wikipedia in the public domain


Please log in for full access
Subscribe to
our newsletters

The EU-Japan Centre currently produces 5 newsletters :

  • EU-Japan NEWS - our flagship newsletter covering the Centre's support services, information about EU (or Member States) - Japan cooperation
  • Japanese Industry and Policy News
  • “About Japan” e-News (Only available for EU companies / EU organisations)
  • Japan Tax and Public Procurement Weekly Tender Digest (Only available for EU companies / EU organisations)
  • Tech Transfer Helpdesk Newsletter
1 EUR = 149,659 JPY